Is autophagy actually required for the lifespan benefit of mTOR inhibition?

Short answer: in worms and flies, yes. In mammals, nobody has tested it. Blocking autophagy genes cancels the lifespan gain from TOR inhibition or dietary restriction in C. elegans, and rapamycin extends fly lifespan through autophagy. In mice the evidence runs one way only: turning autophagy up is enough to make them live longer, but no study has turned it off in mice given rapamycin to see whether the benefit goes away. Being enough (sufficiency) and being needed (necessity) are different claims, and in a mammal only the first has been shown.

Shown in mice: raising autophagy is enough

• PYO2013 A – mice carrying extra copies of the autophagy gene Atg5 lived about 17% longer (median) and were leaner and more insulin-sensitive. No drug was involved: higher autophagy on its own was enough.

A second mouse line points the same way. A Beclin 1 knock-in (F121A) that keeps autophagy running higher also extended lifespan (Fernandez et al., Nature 2018, PMID 29849149). That paper is not in this corpus, which is why it carries no evidence badge.

Two Alzheimer's mouse studies add a weaker strand. They are about disease markers, not lifespan:

• SPI2010 A – long-term rapamycin prevented memory deficits and lowered amyloid-beta in PDAPP mice, and the benefit tracked with higher autophagy in neurons. That is a correlation.
• CAC2010 A – in 3xTg-AD mice rapamycin lowered both amyloid and tau, and the drop in amyloid needed autophagy to be switched on. That is necessity, but for an amyloid readout, not for a longer life.

Shown in worms and flies: autophagy is needed

• HAN2008 A – in C. elegans, blocking autophagy genes abolished the lifespan extension from both dietary restriction and TOR inhibition. The same paper is careful about the limit: autophagy alone did not make worms without DAF-16/FOXO live longer.
• MEL2003 A – worms lacking the autophagy gene bec-1 lost the lifespan benefit of reduced insulin-like signalling.
• BJE2010 A – rapamycin extended fly lifespan through autophagy and through reduced translation. Even in flies, autophagy is one part of the mechanism, not the whole of it.

What's missing

The causal experiment in a mammal. Nobody has blocked autophagy in mice given rapamycin and asked whether the lifespan benefit disappears. If it does, autophagy is required. If lifespan still extends, something else downstream of mTORC1 is doing the work, and higher autophagy is a companion of the benefit rather than its cause. 44 studies in the Atlas are linked to autophagy (19 animal, 19 molecular, 3 reviews, 2 human, 1 preprint); none of them is this experiment. The open part, with a proposed test, has its own page: Is autophagy actually required for the mammalian lifespan benefit?

Why this matters beyond biology trivia

If autophagy isn't strictly required, then drugs or lifestyle interventions that boost autophagy through a completely different pathway (independent of mTOR) might not deliver the same longevity benefit rapamycin does – an assumption a lot of "autophagy-boosting" supplement marketing quietly skips over.

Related entities

Open in the Atlas explorer